People in their 50s with severely narrowed leg arteries may face a high risk for major amputations despite having emergency ...

The incidence of target-lesion revascularization was 6.5, 9.0, and 10.2% at 6, 12 and 24 months, respectively. The MELODIE trial also demonstrated the safety of iliac artery revascularization with ...

St. Luke’s expanded labs allow its heart and vascular team to care for more patients as the need for cardiac and other ...

Persistent over-dilation of muscle microvasculature may be one reason causing chronic limb-threatening ischemia, recent studies by Kuopio University ...

In the year before amputation, a deep divide was seen between patients who got specialist care and those who did not.

Wearable devices can reduce cardiovascular events and death in ischemic heart disease, according to a new meta-analysis, but ...

Medtronic (NYSE: MDT) announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical.

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

The following is a summary of “Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention,” published in the ...

Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and ...

Study reveals regional disparities in access to life-saving stroke treatments in India, highlighting urgent need for improved ...

A new therapeutic device, the Coronary Sinus Reducer (CSR), is making waves in the treatment of refractory angina, providing ...